This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571) Substance Abuse (419)

Published on in Vol 12 (2023)

This is a member publication of Charite - Universitaetsmedizin Berlin, Medizinische Bibliothek, Germany

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38814, first published .
Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey

Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey

Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey

Authors of this article:

Jan Moritz Fischer1 Author Orcid Image ;   Farid-Ihab Kandil1 Author Orcid Image ;   Matthias Karst2 Author Orcid Image ;   Laura Sophie Zager1 Author Orcid Image ;   Michael Jeitler1 Author Orcid Image ;   Felix Kugler1 Author Orcid Image ;   Franziska Fitzner2 Author Orcid Image ;   Andreas Michalsen1, 3 Author Orcid Image ;   Christian S Kessler1, 3 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Fischer J, Kandil F, Katsarova E, Zager L, Jeitler M, Kugler F, Fitzner F, Murthy V, Hanslian E, Wendelmuth C, Michalsen A, Karst M, Kessler C. Patients’ perspectives on prescription cannabinoid therapies: a cross-sectional, exploratory, anonymous, one-time web-based survey among German patients. Frontiers in Medicine 2023;10 View